Toshiba Selects Affymetrix Axiom Platform For Its Genotyping Service In Japan

(RTTNews) - Affymetrix (AFFX) said that its Axiom Genotyping Solution platform has been selected by Toshiba Corporation's (TYO:6502) Healthcare Company as the platform for its newly launched genotyping service.

Affymetrix said it collaborated with Toshiba to custom design and manufacture the Japonica Array, which is based on the Axiom platform. This array contains unique genetic content specifically optimized for the Japanese population.

Toshiba has launched this genotyping service as of Dec. 1, 2014 for Japanese population genotyping studies primarily servicing universities, hospitals, and other research agencies and institutes, according to the company.